Curosurf (poractant alfa) - Chiesi
BuS2020: Efficacy and safety of the intratracheal administration of budesonide with surfactant in very preterm infants to prevent bronchopulmonary dysplasia: randomized clinical trial. (clinicaltrialsregister.eu) - May 28, 2026 - P2/3 | N=60 | Completed | Sponsor: Fundacio De Recerca Clinic Barcelona-Institut DInvestigacions Biomediques August Pi I Sunyer | Not yet recruiting ➔ Completed 
Trial completion • Bronchopulmonary Dysplasia • Pulmonary Disease • Respiratory Diseases
https://euclinicaltrials.eu/ctis-public/view/2024-519980-16-00
 
May 28, 2026
 
Prev Next